Oxlumo (Lumasiran Vials) 94.5mg/0.5ml

OXLUMO (lumasiran) is an injectable medication used for the treatment of primary hyperoxaluria type 1 (PH1). It helps reduce urinary oxalate levels in adults and children. This therapy is administered via subcutaneous injection and is available in vials. Always consult a healthcare provider for personalized guidance.

Strength

94.5mg/0.5ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Alnylam Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OXLUMO (lumasiran) is prescribed to lower high oxalate levels in the urine caused by primary hyperoxaluria type 1 (PH1). PH1 is a rare genetic disorder that leads to excessive oxalate production, which can damage the kidneys and other organs. By reducing oxalate buildup, OXLUMO may help manage symptoms and slow disease progression. It is suitable for both adults and children. Common questions include 'what is OXLUMO used for' and 'how does lumasiran work'.

Side Effects

OXLUMO (lumasiran) works by targeting the production of oxalate in the liver, helping to balance levels in the body. Patients may notice fewer symptoms related to high oxalate, such as kidney stones or urinary issues, over time. The medication is designed to be used regularly to maintain its effects. Individual responses may vary based on metabolism and adherence to treatment.

Precautions & Warnings

OXLUMO (lumasiran) should be handled with care, following proper injection techniques as directed by a healthcare professional. Store vials at room temperature, away from moisture and heat. Keep out of reach of children and pets. Report any unusual reactions, such as injection site reactions or signs of infection, to a doctor promptly. Always discuss your medical history with your healthcare provider before starting treatment.

Avoid Interactions

OXLUMO (lumasiran) may interact with other medications that affect liver enzymes, such as certain antibiotics or antifungals. Alcohol and herbal supplements could also influence its effectiveness. It is important to inform your doctor about all medications and supplements you are taking. Avoid starting or stopping any treatments without professional advice to prevent potential interactions.

Frequently Asked Questions

OXLUMO is given as a subcutaneous injection, typically by a healthcare provider or at home after proper training.

Yes, OXLUMO is approved for use in both adults and children with primary hyperoxaluria type 1.

Common effects may include injection site reactions, such as redness or swelling, and mild gastrointestinal discomfort.

OXLUMO helps manage the condition by reducing oxalate levels but is not a cure for primary hyperoxaluria type 1.

The dosing schedule is determined by a healthcare provider based on individual needs and response to treatment.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.